Profile picture

Doctor Stine Holmen

Oslo University Hospital Rikshospitalet, Oslo (Norway)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Microalbuminuria in heart transplant recipients -insights from the randomized trial dapagliflozin for renal protection in heart transplant recipients (DAPARHT)
Presentation
Microalbuminuria in heart transplant recipients -insights from the randomized trial dapagliflozin for renal protection in heart transplant recipients (DAPARHT)
Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
Presentation
Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

ESC 365 is supported by